Outcomes in Pregnant Adolescent Patients Infected With SARS-CoV-2

被引:3
作者
Nguyen, Anh Quynh [1 ]
Murrin, Ellen [1 ]
Nasrallah, Sebastian [1 ]
Hitchings, Laura [2 ]
Wang, Jenny Q. [1 ]
VanDillen, Michael B. [3 ]
Eletu, Oluwafunmilayo [4 ]
Maxwell, G. Larry [1 ]
Gomez, Luis M. [1 ]
机构
[1] Inova Hlth Syst, Womens Hlth Integrated Res Ctr, Dept Obstet & Gynecol, Falls Church, VA USA
[2] Advarra, Sect IRB Serv, Columbia, MD USA
[3] Univ Tennessee Hlth Sci Ctr, Dept Obstet & Gynecol, Memphis, TN USA
[4] Univ Virginia, Sch Med, Dept Obstet & Gynecol, Charlottesville, VA USA
关键词
COVID-19; pregnancy; adolescents; MORTALITY; COVID-19; CHILDREN;
D O I
10.1097/INF.0000000000003988
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:Pregnant patients with coronavirus disease 2019 (COVID-19) are at risk for adverse pregnancy outcomes. Although clinical outcomes for pregnant adults have been reported, the impact of COVID-19 on adolescents is lacking. We sought to evaluate obstetric outcomes of pregnant adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and compare them with uninfected adolescent controls. Methods:Retrospective cohort study of pregnant adolescents (14-19 years) who had a positive polymerase chain reaction test for SARS-CoV-2 from April 2020 to December 2020 at Inova Health System Hospitals. Controls included pregnant adolescents who tested negative. The primary outcome was a composite of preeclampsia, preterm delivery, cesarean delivery, fetal growth restriction and stillbirth. Secondary outcomes included maternal and neonatal morbidity. Results:Forty-eight pregnant adolescents who tested positive for SARS-CoV-2 were compared with 394 controls. Infected adolescents were more likely to be Hispanic (91.67% vs. 12.18%; risk ratio [RR] 41.85 [95% CI: 15.43-113.5]) and uninsured (50% vs. 7.87%; RR 7.04 [95% CI: 4.31-11.49]. Nearly 80% of infected adolescents remained asymptomatic, whereas one-third of symptomatic adolescents progressed to severe or critical COVID-19. The primary composite outcome was more prevalent in infected adolescents compared with noninfected controls (41.67% vs. 25.38%; adjusted RR 2.65 [95% CI: 1.19-5.93]). Maternal morbidity was more prevalent in infected adolescents (6.25% vs. 0.76%; adjusted RR 9.53 [95% CI: 3.83-23.71]). Primary and secondary maternal outcomes were more prevalent in younger adolescents and those with higher severity of COVID-19. Maternal SARS-CoV-2 infection was not associated with neonatal morbidity. Conclusions:Pregnant adolescents infected with SARS-CoV-2 are more likely to have adverse obstetric outcomes and maternal morbidity compared with noninfected pregnant adolescents.
引用
收藏
页码:781 / 786
页数:6
相关论文
共 50 条
[41]   SARS-CoV-2 and RSV bronchiolitis outcomes [J].
Mendez, Donna R. ;
Paul, Krishna ;
Richardson, Joan ;
Jehle, Dietrich .
HEART & LUNG, 2024, 68 :126-130
[42]   Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants [J].
Gunadi ;
Hakim, Mohamad Saifudin ;
Wibawa, Hendra ;
Vujira, Khanza Adzkia ;
Puspitarani, Dyah Ayu ;
Supriyati, Endah ;
Trisnawati, Ika ;
Iskandar, Kristy ;
El Khair, Riat ;
Afiahayati ;
Siswanto ;
Puspadewi, Yunika ;
Irianingsih, Sri Handayani ;
Nugrahaningsih, Dwi Aris Agung ;
Eryvinka, Laudria Stella ;
Utami, Fadila Dyah Trie ;
Devana, Edita Mayda ;
Aditama, Lanang ;
Kinasih, Nathania Christi Putri ;
Hediningsih, Yekti ;
Ananda, Nur Rahmi ;
Arguni, Eggi ;
Nuryastuti, Titik ;
Wibawa, Tri .
BMC MEDICAL GENOMICS, 2023, 16 (01)
[43]   Smell Status in Children Infected with SARS-CoV-2 [J].
Rusetsky, Yury ;
Meytel, Irina ;
Mokoyan, Zhanna ;
Fisenko, Andrey ;
Babayan, Anna ;
Malyavina, Ulyana .
LARYNGOSCOPE, 2021, 131 (08) :E2475-E2480
[44]   Maternal and neonatal outcomes following SARS-CoV-2 infection [J].
Boettcher, Lillian B. ;
Metz, Torri D. .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2023, 28 (01)
[45]   Evaluation of prognostic markers in patients infected with SARS-CoV-2 [J].
Mandal, Dipendra Kumar ;
Chhusyabaga, Mandira ;
Pokhrel, Sushant ;
Bhattarai, Bibek Raj ;
Aryal, Suraj ;
Nepal, Richa ;
Bastola, Anup ;
Baral, Soma Kanta ;
Bhatt, Mahendra Prasad ;
Marahatta, Sujan Babu ;
Sah, Shiv Kumar .
OPEN LIFE SCIENCES, 2022, 17 (01) :1360-1370
[46]   Drug repurposing for the treatment of patients infected with SARS-CoV-2 [J].
Martins, Guilherme F. ;
Castro, Thiago S. ;
Ferreira, Davi A. C. .
NETWORK MODELING AND ANALYSIS IN HEALTH INFORMATICS AND BIOINFORMATICS, 2024, 13 (01)
[47]   Catalase Activity of IgGs of Patients Infected with SARS-CoV-2 [J].
Tolmacheva, Anna S. ;
Onvumere, Margarita K. ;
Sedykh, Sergey E. ;
Timofeeva, Anna M. ;
Nevinsky, Georgy A. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
[48]   Nurses perspective of apheresis in SARS-CoV-2 infected patients [J].
Tjoelker, Linda ;
Vrielink, Hans .
TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (02)
[49]   SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy [J].
Madeira, Mayara Ponte ;
Freire, Erika Bastos Lima ;
Fernandes, Virginia Oliveira ;
da Cruz Paiva Lima, Grayce Ellen ;
Melo, Ivana da Ponte ;
Rangel Montenegro, Ana Paula Dias ;
da Cruz Freire, Jose Ednesio ;
Aquino Moreira-Nunes, Caroline De Fatima ;
Montenegro, Raquel Carvalho ;
Colares, Jeova Keny Baima ;
Montenegro Junior, Renan Magalhaes .
DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01)
[50]   Prognostic Factors for Mortality in Maintenance Hemodialysis Patients Infected with SARS-CoV-2 [J].
Yamada, Takehisa ;
Sakai, Yukinao ;
Kashiwagi, Tetsuya ;
Iwabu, Masato .
JOURNAL OF NIPPON MEDICAL SCHOOL, 2024, 91 (06) :520-526